A senior executive at Texas Instruments Inc. (NASDAQ: TXN) has executed a notable sale of common stock. Ahmad Bahai, who serves as Senior Vice President at the semiconductor firm, sold 5,000 shares of common stock on May 14, 2026. The total value realized from this divestment amounted to $1,545,636. The executed sale involved a price range spanning from $308.85 to $309.53 per share.
The timing of the sale is contextualized by TXN's recent market performance. At the time of the transaction, the stock was trading slightly below its 52-week peak valuation of $310.29. This current level follows a substantial upward trajectory for the company over the preceding six months, marked by an impressive 96% surge in value.
The shares sold were acquired through the exercise of non-qualified stock options. Mr. Bahai exercised 5,000 such options, which allowed him to purchase common stock at a fixed exercise price of $110.15 per share, resulting in an initial cost basis of $550,750 for the shares.
These specific stock options had structured vesting terms. They were initially set to become exercisable through four equal annual installments, with the first installment beginning on January 25, 2019, and were scheduled to expire on January 25, 2028.
Following the completion of these transactions, Mr. Bahai's direct holdings in Texas Instruments common stock totaled 42,519 shares. In addition to his outright equity stake, he maintains an additional holding of 16,534 derivative shares structured as stock options.
Despite the reported insider selling activity, Texas Instruments remains a key focus for institutional analysts. The company has recently garnered significant attention due to multiple firms adjusting their price targets and issuing updated recommendations following recent operational performance and future guidance.
For example, BofA Securities reaffirmed its Buy rating on TXN and established a new price target of $320. This upgrade was predicated on observing a broad recovery within the company's first-quarter results and continued strength noted in the second-quarter outlook. Similarly, UBS maintained a positive Buy rating while increasing its price target to $295. UBS highlighted the strong free cash flow prognosis and consistent performance observed across both the industrial and data center market segments.
Other analysts have also adjusted their views. Truist Securities raised its price target to $278, while retaining a Hold rating. This firm pointed to evidence of demand recovery extending beyond the immediate growth areas of artificial intelligence (AI) and data centers, suggesting strength in broader industrial applications. Furthermore, Stifel increased its price target to $340, maintaining a Buy recommendation after holding discussions with both Texas Instruments' VP and Head of Investor Relations. Cantor Fitzgerald also adjusted its target up to $300, while keeping a Neutral rating, citing the company’s inherent pricing power and established internal manufacturing capabilities as potential competitive advantages.
The collective actions from these financial institutions paint a picture of generally positive sentiment regarding Texas Instruments' operational trajectory and future earning potential. These varied analyst reports collectively underscore an ongoing focus on TXN's market position within the semiconductor sector, particularly concerning its ability to capitalize on demand across diverse industrial markets.